Advertisement

Mobile Banner
Mobile Banner
Mobile Banner
Loading...

Harvey Norman Holdings Limited

HNORY•PNK
Consumer Cyclical
Specialty Retail
$12.50
$-10.07(-44.62%)
U.S. Market opens in 8h 25m

Harvey Norman Holdings Limited (HNORY) Stock Overview

Explore Harvey Norman Holdings Limited’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap3.1B
P/E Ratio8.52
EPS (TTM)$1.13
ROE0.11%
Fundamental Analysis

AI Price Forecasts

1 Month$14.76
3 Months$11.86
1 Year Target$13.77

HNORY Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Harvey Norman Holdings Limited (HNORY) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 48.15, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $13.77.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 8.52 and a market capitalization of 3.1B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-44.62%
5-Day Change
N/A
1-Month Change
N/A
3-Month Change
N/A
6-Month Change
N/A
Year-to-Date (YTD) Change
N/A
1-Year Change
-29.02%
3-Year Change
-18.62%
5-Year Change
-41.62%
All-Time (Max) Change
-27.03%

Contact Information

https://www.harveynormanholdings.com.au
61 2 9201 6111
A1 Richmond Road, Homebush West, NSW, 2140

Company Facts

65,000 Employees
IPO DateApr 15, 2015
CountryAU
Actively Trading

Frequently Asked Questions